Richard Derek

Richard Derek is a Professor specializing in cancer biology and molecular oncology, with a focus on DNA repair mechanisms, epigenetics, and therapeutic strategies for cancer treatment. His research integrates genomic instability, drug delivery systems, and targeted therapies to address challenges in treating cancers such as lung, breast, and colorectal cancers. Collaborations with institutions like the University of Queensland (inferred via co-authors) highlight his interdisciplinary approach to advancing cancer research.

• Key research areas include:
• Epigenetic drug development
• DNA double-strand break repair pathways
• Nanoparticle-based drug delivery for lung cancer
• Protein interactions in cancer progression

Recent work explores the role of COMMD4, hSSB1, and Banf1 proteins in cancer pathogenesis and therapy response, with implications for personalized medicine and novel therapeutic targets.